Ginkgo Bioworks Holdings IncNYSE:DNA
- LAST PRICE7.8800
- TODAY'S CHANGE (%)0.7000 (9.7493%)
- Bid / Lots7.8700/ 2
- Ask / Lots7.9000/ 1
- Open / Previous Close7.4100 / 7.1800
- Day Range
- 52 Week Range
- Volume869,226
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | DNA |
|---|---|---|
| 09:32 ET | 36418 | 7.58 |
| 09:33 ET | 20802 | 7.6 |
| 09:35 ET | 37477 | 7.68 |
| 09:37 ET | 13812 | 7.78 |
| 09:39 ET | 19341 | 7.59 |
| 09:42 ET | 2328 | 7.63 |
| 09:44 ET | 5364 | 7.615 |
| 09:46 ET | 4025 | 7.5804 |
| 09:48 ET | 4362 | 7.645 |
| 09:50 ET | 2829 | 7.62 |
| 09:51 ET | 3121 | 7.61 |
| 09:53 ET | 3185 | 7.565 |
| 09:55 ET | 7749 | 7.42 |
| 09:57 ET | 19340 | 7.41 |
| 10:00 ET | 7018 | 7.5 |
| 10:02 ET | 8498 | 7.46 |
| 10:04 ET | 3319 | 7.495 |
| 10:06 ET | 3215 | 7.53 |
| 10:08 ET | 6594 | 7.59 |
| 10:09 ET | 43379 | 7.625 |
| 10:11 ET | 2691 | 7.68 |
| 10:13 ET | 3999 | 7.59 |
| 10:15 ET | 5132 | 7.68 |
| 10:18 ET | 9776 | 7.79 |
| 10:20 ET | 15959 | 7.88 |
| 10:22 ET | 22769 | 7.96 |
| 10:24 ET | 5741 | 7.95 |
| 10:26 ET | 10430 | 7.87 |
| 10:27 ET | 25575 | 7.87 |
| 10:29 ET | 11259 | 7.77 |
| 10:31 ET | 7248 | 7.745 |
| 10:33 ET | 14049 | 7.759 |
| 10:36 ET | 11149 | 7.73 |
| 10:38 ET | 4230 | 7.81 |
| 10:40 ET | 8663 | 7.8514 |
| 10:42 ET | 2157 | 7.82 |
| 10:44 ET | 2008 | 7.88 |
| 10:45 ET | 5203 | 7.84 |
| 10:47 ET | 17873 | 7.895 |
| 10:49 ET | 1646 | 7.91 |
| 10:51 ET | 10458 | 7.945 |
| 10:54 ET | 3609 | 7.98 |
| 10:56 ET | 13102 | 8.01 |
| 10:58 ET | 8226 | 8.01 |
| 11:00 ET | 1501 | 7.99 |
| 11:02 ET | 15071 | 7.945 |
| 11:03 ET | 27464 | 7.96 |
| 11:05 ET | 602 | 8 |
| 11:07 ET | 3460 | 7.99 |
| 11:09 ET | 900 | 7.945 |
| 11:12 ET | 2597 | 7.915 |
| 11:14 ET | 2038 | 7.9669 |
| 11:16 ET | 8094 | 7.9891 |
| 11:18 ET | 19552 | 7.97 |
| 11:20 ET | 910 | 7.91 |
| 11:21 ET | 5454 | 7.93 |
| 11:23 ET | 1062 | 7.91 |
| 11:25 ET | 3786 | 7.94 |
| 11:27 ET | 3840 | 7.88 |
| 11:30 ET | 1523 | 7.87 |
| 11:32 ET | 1400 | 7.86 |
| 11:34 ET | 1200 | 7.9003 |
| 11:36 ET | 2699 | 7.85 |
| 11:38 ET | 825 | 7.86 |
| 11:39 ET | 724 | 7.89 |
| 11:41 ET | 2829 | 7.87 |
| 11:45 ET | 3605 | 7.84 |
| 11:48 ET | 965 | 7.84 |
| 11:50 ET | 2546 | 7.84 |
| 11:52 ET | 1131 | 7.86 |
| 11:54 ET | 900 | 7.89 |
| 11:56 ET | 5912 | 7.855 |
| 11:57 ET | 100 | 7.87 |
| 11:59 ET | 400 | 7.89 |
| 12:01 ET | 100 | 7.9 |
| 12:03 ET | 3982 | 7.87 |
| 12:06 ET | 13075 | 7.85 |
| 12:08 ET | 367 | 7.88 |
| 12:10 ET | 2928 | 7.85 |
| 12:12 ET | 5004 | 7.826 |
| 12:14 ET | 21850 | 7.77 |
| 12:15 ET | 7487 | 7.74 |
| 12:17 ET | 2517 | 7.79 |
| 12:19 ET | 424 | 7.78 |
| 12:21 ET | 3374 | 7.75 |
| 12:24 ET | 3828 | 7.735 |
| 12:26 ET | 550 | 7.75 |
| 12:28 ET | 1100 | 7.75 |
| 12:30 ET | 609 | 7.79 |
| 12:32 ET | 7552 | 7.71 |
| 12:33 ET | 267 | 7.7428 |
| 12:35 ET | 1577 | 7.755 |
| 12:37 ET | 1246 | 7.77 |
| 12:39 ET | 2625 | 7.785 |
| 12:42 ET | 5316 | 7.8195 |
| 12:44 ET | 1200 | 7.795 |
| 12:46 ET | 6588 | 7.825 |
| 12:48 ET | 4765 | 7.75 |
| 12:50 ET | 749 | 7.81 |
| 12:53 ET | 1700 | 7.795 |
| 12:55 ET | 895 | 7.83 |
| 12:57 ET | 681 | 7.8182 |
| 01:00 ET | 225 | 7.82 |
| 01:02 ET | 2200 | 7.84 |
| 01:04 ET | 267 | 7.82 |
| 01:06 ET | 300 | 7.835 |
| 01:08 ET | 2741 | 7.85 |
| 01:09 ET | 2500 | 7.8126 |
| 01:11 ET | 100 | 7.8 |
| 01:13 ET | 516 | 7.835 |
| 01:15 ET | 1300 | 7.85 |
| 01:20 ET | 1251 | 7.835 |
| 01:22 ET | 2262 | 7.88 |
| 01:24 ET | 7114 | 7.89 |
| 01:26 ET | 3081 | 7.9 |
| 01:27 ET | 6758 | 7.855 |
| 01:29 ET | 901 | 7.85 |
| 01:31 ET | 3900 | 7.92 |
| 01:33 ET | 4975 | 7.94 |
| 01:36 ET | 450 | 7.96 |
| 01:38 ET | 1532 | 7.97 |
| 01:40 ET | 1575 | 7.9829 |
| 01:42 ET | 7590 | 7.94 |
| 01:44 ET | 1946 | 7.9228 |
| 01:45 ET | 5780 | 7.91 |
| 01:47 ET | 2765 | 7.9 |
| 01:49 ET | 220 | 7.89 |
| 01:51 ET | 100 | 7.88 |
Nov 12, 2024
Press Release: Ginkgo Bioworks Reports Third Quarter 2024 Financial Results, from 5:01PM ET on Tuesday Nov 12, 2024 by Dow Jones
5:01PM ET on Tuesday Nov 12, 2024 by Dow JonesGinkgo Bioworks Reports Third Quarter 2024 Financial Results, from 5:01PM ET on Tuesday Nov 12, 2024 by Dow Jones
5:01PM ET on Tuesday Nov 12, 2024 by Dow JonesGinkgo Bioworks Advances Collaboration with Merck to Improve Biologics Manufacturing, from 8:01AM ET on Tuesday Nov 12, 2024 by Dow Jones
8:01AM ET on Tuesday Nov 12, 2024 by Dow Jones
Nov 5, 2024
Ginkgo Bioworks Announces Date of Third Quarter 2024 Results Presentation, from 7:00AM ET on Tuesday Nov 05, 2024 by Dow Jones
7:00AM ET on Tuesday Nov 05, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Ginkgo Bioworks Holdings Inc | 412.7M | -0.6x | --- |
Voyager Therapeutics Inc | 308.4M | 9.9x | --- |
Revance Therapeutics Inc | 391.3M | -2.0x | --- |
Coherus BioSciences Inc | 125.6M | -14.5x | --- |
Akebia Therapeutics Inc | 410.2M | -8.8x | --- |
Sangamo Therapeutics Inc | 391.5M | -2.6x | --- |
Company Information
Ginkgo Bioworks Holdings, Inc. operates as a horizontal platform for cell programming, providing end-to-end services for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Its segments include Cell Engineering and Biosecurity. The Cell Engineering consists of research and development services performed under collaboration and license agreements relating to its cell programming platform. Its cell programming platform includes two core assets: the Foundry, and Codebase. The Biosecurity segment consists of biomonitoring and bioinformatic testing products and services primarily provided to public health authorities. It also focuses on the design of next-generation cell therapies for autoimmune diseases. It uses its platform to develop and screen libraries of novel NK-specific and T-cell specific chimeric antigen receptor and switch receptor designs, which enable control and performance of immune cell-based therapies.
Contact Information
- Headquarters
- 27 Drydock Avenue, 8Th FloorBOSTON, MA, United States 02210
- Phone
- 310-209-7280
- Fax
- 302-655-5049
Executives
- Independent Non-Executive Chairman of the Board
- Shyam Sankar
- President, Chief Operating Officer, Director
- Reshma Shetty
- Chief Executive Officer, Director
- Jason Kelly
- Chief Financial Officer
- Mark Dmytruk
- Director
- Sri Kosuri
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $412.7M |
|---|---|
Revenue (TTM) | $218.0M |
Shares Outstanding | 57.5M |
Ginkgo Bioworks Holdings Inc does not pay a dividend. | |
Beta | 1.08 |
EPS | $-12.90 |
Book Value | $21.93 |
P/E Ratio | -0.6x |
Price/Sales (TTM) | 1.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -318.37% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
